Frankfurt - Delayed Quote EUR
Adverum Biotechnologies, Inc. (AVU0.F)
2.5000
-0.0200
(-0.79%)
As of 8:06:32 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.75M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.98 - 3.00 per share. | Indirect | 1,048,950 | Apr 23, 2025 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.04 - 4.38 per share. | Indirect | 147,076 | Apr 2, 2025 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.04 - 5.19 per share. | Direct | 188,931 | Mar 27, 2025 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.60 - 5.61 per share. | Indirect | 587,575 | Mar 20, 2025 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.01 - 4.60 per share. | Indirect | 1,439,087 | Feb 28, 2025 |
| SOPARKAR PETER Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2025 |
| OZDEN RABIA GURSES Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2025 |
| SEYEDKAZEMI SETAREH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2025 |
| RUBINSTEIN LINDA M. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2025 |
| FISCHER LAURENT D M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2025 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.15 per share. | Indirect | 613,470 | Jul 30, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.75 - 9.11 per share. | Indirect | 1,785,662 | Jul 18, 2024 |
| SCOPA JAMES PAUL Director | Purchase at price 1.35 per share. | Direct | 135,000 | Feb 7, 2024 |
| LUPHER MARK L. JR., PH.D. Director | Purchase at price 1.35 per share. | Indirect | 175,500 | Feb 7, 2024 |
| SEYEDKAZEMI SETAREH Officer | Sale at price 1.52 - 1.55 per share. | Direct | 9,429 | Sep 15, 2023 |
| RUBINSTEIN LINDA M. Chief Financial Officer | Purchase at price 1.45 per share. | Direct | 145,490 | Jun 7, 2023 |
Related Tickers
1JK.F Apellis Pharmaceuticals, Inc.
15.14
+3.73%
1T3.F Syndax Pharmaceuticals, Inc.
11.50
+0.88%
F6T.F Fate Therapeutics, Inc.
1.0760
-2.09%
THRD Third Harmonic Bio, Inc.
5.17
+0.29%
SION Sionna Therapeutics, Inc.
12.03
-0.08%
UPB Upstream Bio, Inc.
9.18
+4.50%
FULC Fulcrum Therapeutics, Inc.
3.7100
+3.92%
TENX Tenax Therapeutics, Inc.
5.81
-1.19%
KYTX Kyverna Therapeutics, Inc.
2.0609
+0.53%
SNDX Syndax Pharmaceuticals, Inc.
13.64
+1.64%